The short version
- Why people research itAnti-inflammatory / immune modulation (CIRS and airway interest).
- What the evidence isAviptadil — synthetic VIP — has been through randomized human trials, most prominently in COVID-19 respiratory failure, where results were mixed and did not support approval.
- What to watchFainting or a very fast pulse.
How VIP works
Neuropeptide with broad anti-inflammatory and immune-balancing effects; used in CIRS/mold recovery protocols, often nasal.
VIP is a 28-residue peptide of the secretin/glucagon superfamily and it works through two class B G-protein-coupled receptors, VPAC1 and VPAC2. Both couple to Gs, so both do the same chemical thing: activate adenylate cyclase, raise intracellular cAMP, activate protein kinase A.
That single-messenger architecture is the whole problem with the drug, and it is worth being explicit about. Raise cAMP in vascular smooth muscle and you get vasodilation. Raise it in airway smooth muscle and you get bronchodilation.
- Injectable
- Nasal
Research on VIP5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Aviptadil — synthetic VIP — has been through randomized human trials, most prominently in COVID-19 respiratory failure, where results were mixed and did not support approval. It is also approved in Europe in combination with phentolamine for erectile dysfunction.
Inhaled VIP has been trialed in pulmonary arterial hypertension and sarcoidosis with small positive signals.
Correlative data
Used intranasally in chronic inflammatory response syndrome protocols, where the published support is essentially one clinician's case series rather than controlled data. Reported experience is highly variable.
How the mechanism reads
A 28-amino-acid neuropeptide acting on VPAC1/VPAC2 receptors — it is a potent vasodilator, bronchodilator and anti-inflammatory, concentrated in the lung and gut.
MechanisticIt is also degraded within minutes in serum, which is why delivery route dominates whether it does anything at all.
Mechanistic
Sources
- Domschke S. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut 1978 · PMID 730072
- Chayvialle JA. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs. Gut 1981 · PMID 6117506
- Burian B. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients. Peptides 2010 · PMID 20026142
- Petkov V. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest 2003 · PMID 12727925
- Leuchte HH. Inhalation of vasoactive intestinal peptide in pulmonary hypertension. Eur Respir J 2008 · PMID 18978135
- Youssef JG, Lavin P, Schoenfeld DA, Lee RA, Lenhardt R, Park DJ, Fernandez JP, Morganroth ML, Javitt JC, Jayaweera D. The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.. Crit Care Med 2022 · PMID 36044317
- Brown SM. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.. Lancet Respir Med 2023 · PMID 37348524
- Lee WL. A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure.. Lancet Respir Med 2023 · PMID 37348523
VIP safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Low blood pressure or fainting episodes: VIP is a vasodilator.
- Chronic watery diarrhea: VIP drives intestinal secretion.
- Pregnancy or breastfeeding: VIP relaxes smooth muscle, including the uterus, with no safety data.
- Heart rhythm disorders: VIP can raise heart rate.
What’s expected
- Flushing, warmth and a mild blood pressure drop.
- A runny or congested nose with the nasal route.
- Looser stools.
- Possibly less inflammatory symptoms in mold-illness protocols.
Watch for
- Fainting or a very fast pulse.
- Watery diarrhea with weakness.
- Facial swelling while using VIP.
- Severe headache while using VIP.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- hs-CRP (C-Reactive Protein, High Sensitivity)
- TNF-Alpha (Tumor Necrosis Factor)
- TGF Beta-1
VIP is a vasodilating neuropeptide with broad anti-inflammatory action; pressure and gut secretion are its harms, and cytokine labs are its readout. PMID 730072 PMID 12727925
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
VIP FAQ4 common questions
- Is VIP approved for human use?
- No. VIP is a research compound.
- What is VIP researched for?
- Anti-inflammatory / immune modulation (CIRS and airway interest).
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; hs-CRP; TNF-Alpha; TGF Beta-1: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for VIP: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





